Alterity Therapeutics Limited
ATH
Classement en actions
#26058
Based in Melbourne, Australia, Alterity Therapeutics Limited, founded in 1997,... Based in Melbourne, Australia, Alterity Therapeutics Limited, founded in 1997, is dedicated to the discovery and advancement of treatments for neurological conditions such as Alzheimer's, Huntington's, and Parkinson's diseases, among others. The company's primary drug candidate, ATH434, has successfully navigated Phase I clinical trials for Parkinson's disease. Additionally, it is progressing PBT2, an investigational compound for Alzheimer's disease that has completed Phase 2a clinical trials. The firm, previously known as Prana Biotechnology Limited, adopted its current name, Alterity Therapeutics Limited, in April 2019.
Prix de l'action
$0.1844102
Capitalisation boursière
$40.29M
Changement (1 jour)
2.94%
Changement (1 an)
-47.31%
Pays
AU
Échange Alterity Therapeutics Limited (ATH)
Catégorie
Healthcare
Historique du prix de l'action pour Alterity Therapeutics Limited (ATH)
Prix de clôture le plus élevé : $0.33 le 2026-10-01
Prix de clôture le plus bas : $13.50 le 2012-09-01
Prix de clôture le plus bas : $13.50 le 2012-09-01
Historique du prix de l'action de Alterity Therapeutics Limited de 2012 à 2026
Performance annuelle du prix de l'action
| Année | Performance |
|---|---|
| 2026 (TTM) | -12.13% |
| 2025 | 75.00% |
| 2024 | -18.18% |
| 2023 | -37.61% |
| 2022 | -59.70% |
| 2021 | -39.12% |
| 2020 | 63.99% |
| 2019 | -39.67% |
| 2018 | -32.87% |
| 2017 | 8.20% |
| 2016 | -48.69% |
| 2015 | -55.45% |
| 2014 | -69.99% |
| 2013 | 162.07% |
| 2012 | 0.00% |
Prix de l'action pour des entreprises similaires ou concurrentes
| Entreprise | Prix de l'action | Variation 1a% | Pays |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $251.29 | 835.90% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $890.85 | 9.42% |
NL
|
|
| $760.40 | 8.08% |
CH
|
